APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dry Powder Inhaler Device

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

Selected research

Industry Growth & Trends

Global Dry Powder Inhaler Device Industry Growth and Trends Forecast to 2032

1 January 2026100 pages

Choose your research edition.

Industry ResearchDry Powder Inhaler Device Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Dry Powder Inhaler Device Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Dry Powder Inhaler Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dry Powder Inhaler Device Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Dry Powder Inhaler Device Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.

GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, etc. are the key players in the global Dry Powder Inhaler Device market. Top 4 took up more than 30% of the global market.

From the view of region, USA have a larger consumption market share which account for about 35% of total share. Europe hold a market share of about 25%. In addition, Asia Pacific is also play important role in Global market.

Read the full market overview

Dry Powder Inhaler Device main application area is Asthma This sector hold a market share of over 80%. Then followed by the COPD.

According to the Segmentation of types, all the market of Dry Powder Inhaler Device can be divided as follows: Multi-dose, Single-dose.

Report Scope

This report provides a structured, data-driven view of the global Dry Powder Inhaler Device market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dry Powder Inhaler Device market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dry Powder Inhaler Device market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dry Powder Inhaler Device.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dry Powder Inhaler Device market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dry Powder Inhaler Device Market by Company

GlaxoSmithKline

AstraZeneca

Boehringer Ingelheim

Chiesi

Cipla

3M

Hovione

Mannkind

Mylan

Novartis

Schering/Merck

Teva

Vectura

Dry Powder Inhaler Device Segment by Type

Single Dose

Multi Dose

Dry Powder Inhaler Device Segment by Application

Asthma

COPD

Others

Dry Powder Inhaler Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Inhaler Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Inhaler Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Inhaler Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dry Powder Inhaler Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Dose Table 2. Major Company of Multi Dose Table 3. Global Dry Powder Inhaler Device Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dry Powder Inhaler Device Sales by Type (2021-2026) & (K Units) Table 5. Global Dry Powder Inhaler Device Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dry Powder Inhaler Device Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dry Powder Inhaler Device Sales Market Share in Value by Type (2021-2026) Table 8. Global Dry Powder Inhaler Device Price by Type (2021-2026) & (USD/Unit) Table 9. Global Dry Powder Inhaler Device Sales by Type (2027-2032) & (K Units) Table 10. Global Dry Powder Inhaler Device Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dry Powder Inhaler Device Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dry Powder Inhaler Device Sales Market Share in Value by Type (2027-2032) Table 13. Global Dry Powder Inhaler Device Price by Type (2027-2032) & (USD/Unit) Table 14. North America Dry Powder Inhaler Device Sales by Type (2021-2026) & (K Units) Table 15. North America Dry Powder Inhaler Device Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dry Powder Inhaler Device Sales by Type (2021-2026) & (K Units) Table 17. Europe Dry Powder Inhaler Device Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dry Powder Inhaler Device Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Dry Powder Inhaler Device Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dry Powder Inhaler Device Sales by Type (2021-2026) & (K Units) Table 21. Latin America Dry Powder Inhaler Device Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dry Powder Inhaler Device Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Dry Powder Inhaler Device Sales by Type (2021-2026) & (US$ Million) Table 24. Dry Powder Inhaler Device Industry Trends Table 25. Dry Powder Inhaler Device Industry Drivers Table 26. Dry Powder Inhaler Device Industry Opportunities and Challenges Table 27. Dry Powder Inhaler Device Industry Restraints Table 28. Global Dry Powder Inhaler Device Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dry Powder Inhaler Device Revenue Market Share by Company (2021-2026) Table 30. Global Dry Powder Inhaler Device Sales by Company (2021-2026) & (K Units) Table 31. Global Dry Powder Inhaler Device Sales Share by Company (2021-2026) Table 32. Global Dry Powder Inhaler Device Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Dry Powder Inhaler Device Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dry Powder Inhaler Device Major Company Production Sites and Headquarters Table 35. Global Dry Powder Inhaler Device Company, Product Type & Application Table 36. Global Dry Powder Inhaler Device Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dry Powder Inhaler Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dry Powder Inhaler Device Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dry Powder Inhaler Device Sales by Region (2021-2026) & (K Units) Table 41. Global Dry Powder Inhaler Device Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dry Powder Inhaler Device Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dry Powder Inhaler Device Sales Market Share in Value by Region (2021-2026) Table 44. Global Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Dry Powder Inhaler Device Sales by Region (2027-2032) & (K Units) Table 46. Global Dry Powder Inhaler Device Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dry Powder Inhaler Device Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dry Powder Inhaler Device Sales Market Share in Value by Region (2027-2032) Table 49. Global Dry Powder Inhaler Device Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Dry Powder Inhaler Device Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dry Powder Inhaler Device Sales by Application (2021-2026) & (K Units) Table 52. Global Dry Powder Inhaler Device Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dry Powder Inhaler Device Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dry Powder Inhaler Device Sales Market Share in Value by Application (2021-2026) Table 55. Global Dry Powder Inhaler Device Price by Application (2021-2026) & (USD/Unit) Table 56. Global Dry Powder Inhaler Device Sales by Application (2027-2032) & (K Units) Table 57. Global Dry Powder Inhaler Device Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dry Powder Inhaler Device Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dry Powder Inhaler Device Sales Market Share in Value by Application (2027-2032) Table 60. Global Dry Powder Inhaler Device Price by Application (2027-2032) & (USD/Unit) Table 61. North America Dry Powder Inhaler Device Sales by Application (2021-2026) & (K Units) Table 62. North America Dry Powder Inhaler Device Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dry Powder Inhaler Device Sales by Application (2021-2026) & (K Units) Table 64. Europe Dry Powder Inhaler Device Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dry Powder Inhaler Device Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Dry Powder Inhaler Device Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dry Powder Inhaler Device Sales by Application (2021-2026) & (K Units) Table 68. Latin America Dry Powder Inhaler Device Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dry Powder Inhaler Device Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Dry Powder Inhaler Device Sales by Application (2021-2026) & (US$ Million) Table 71. GlaxoSmithKline Company Information Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio Table 75. GlaxoSmithKline Recent Development Table 76. AstraZeneca Company Information Table 77. AstraZeneca Business Overview Table 78. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. AstraZeneca Dry Powder Inhaler Device Product Portfolio Table 80. AstraZeneca Recent Development Table 81. Boehringer Ingelheim Company Information Table 82. Boehringer Ingelheim Business Overview Table 83. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio Table 85. Boehringer Ingelheim Recent Development Table 86. Chiesi Company Information Table 87. Chiesi Business Overview Table 88. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Chiesi Dry Powder Inhaler Device Product Portfolio Table 90. Chiesi Recent Development Table 91. Cipla Company Information Table 92. Cipla Business Overview Table 93. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Cipla Dry Powder Inhaler Device Product Portfolio Table 95. Cipla Recent Development Table 96. 3M Company Information Table 97. 3M Business Overview Table 98. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. 3M Dry Powder Inhaler Device Product Portfolio Table 100. 3M Recent Development Table 101. Hovione Company Information Table 102. Hovione Business Overview Table 103. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Hovione Dry Powder Inhaler Device Product Portfolio Table 105. Hovione Recent Development Table 106. Mannkind Company Information Table 107. Mannkind Business Overview Table 108. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Mannkind Dry Powder Inhaler Device Product Portfolio Table 110. Mannkind Recent Development Table 111. Mylan Company Information Table 112. Mylan Business Overview Table 113. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Mylan Dry Powder Inhaler Device Product Portfolio Table 115. Mylan Recent Development Table 116. Novartis Company Information Table 117. Novartis Business Overview Table 118. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Novartis Dry Powder Inhaler Device Product Portfolio Table 120. Novartis Recent Development Table 121. Schering/Merck Company Information Table 122. Schering/Merck Business Overview Table 123. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Schering/Merck Dry Powder Inhaler Device Product Portfolio Table 125. Schering/Merck Recent Development Table 126. Teva Company Information Table 127. Teva Business Overview Table 128. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Teva Dry Powder Inhaler Device Product Portfolio Table 130. Teva Recent Development Table 131. Vectura Company Information Table 132. Vectura Business Overview Table 133. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Vectura Dry Powder Inhaler Device Product Portfolio Table 135. Vectura Recent Development Table 136. North America Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 138. North America Dry Powder Inhaler Device Sales Market Share by Country (2021-2026) Table 139. North America Dry Powder Inhaler Device Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Dry Powder Inhaler Device Sales Market Share Forecast by Country (2027-2032) Table 141. North America Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Dry Powder Inhaler Device Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Dry Powder Inhaler Device Market Share by Country (2021-2026) Table 144. North America Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Dry Powder Inhaler Device Market Share Forecast by Country (2027-2032) Table 146. Europe Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 148. Europe Dry Powder Inhaler Device Sales Market Share by Country (2021-2026) Table 149. Europe Dry Powder Inhaler Device Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Dry Powder Inhaler Device Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Dry Powder Inhaler Device Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Dry Powder Inhaler Device Market Share by Country (2021-2026) Table 154. Europe Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Dry Powder Inhaler Device Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Dry Powder Inhaler Device Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Dry Powder Inhaler Device Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Dry Powder Inhaler Device Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Dry Powder Inhaler Device Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Dry Powder Inhaler Device Market Share by Country (2021-2026) Table 164. Asia-Pacific Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Dry Powder Inhaler Device Market Share Forecast by Country (2027-2032) Table 166. Latin America Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 168. Latin America Dry Powder Inhaler Device Sales Market Share by Country (2021-2026) Table 169. Latin America Dry Powder Inhaler Device Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Dry Powder Inhaler Device Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Dry Powder Inhaler Device Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Dry Powder Inhaler Device Market Share by Country (2021-2026) Table 174. Latin America Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Dry Powder Inhaler Device Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Dry Powder Inhaler Device Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Dry Powder Inhaler Device Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Dry Powder Inhaler Device Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Dry Powder Inhaler Device Market Share by Country (2021-2026) Table 184. Middle East and Africa Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Dry Powder Inhaler Device Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Dry Powder Inhaler Device Distributors List Table 189. Dry Powder Inhaler Device Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Dry Powder Inhaler Device Image Figure 2. Global Dry Powder Inhaler Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dry Powder Inhaler Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Dry Powder Inhaler Device Sales (2021-2032) & (K Units) Figure 5. Single Dose Image Figure 6. Global Single Dose Sales YoY Growth (2021-2032) & (K Units) Figure 7. Multi Dose Image Figure 8. Global Multi Dose Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Dry Powder Inhaler Device Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dry Powder Inhaler Device Market Share by Type 2025 VS 2032 Figure 11. North America Dry Powder Inhaler Device Sales Market Share in Volume by Type in 2025 Figure 12. North America Dry Powder Inhaler Device Sales Market Share in Value by Type in 2025 Figure 13. Europe Dry Powder Inhaler Device Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dry Powder Inhaler Device Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dry Powder Inhaler Device Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dry Powder Inhaler Device Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dry Powder Inhaler Device Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dry Powder Inhaler Device Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dry Powder Inhaler Device Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dry Powder Inhaler Device Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Asthma Image Figure 24. Global Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 25. COPD Image Figure 26. Global COPD Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Dry Powder Inhaler Device Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Dry Powder Inhaler Device Market Share by Application 2025 VS 2032 Figure 31. North America Dry Powder Inhaler Device Sales Market Share in Volume by Application in 2025 Figure 32. North America Dry Powder Inhaler Device Sales Market Share in Value by Application in 2025 Figure 33. Europe Dry Powder Inhaler Device Sales Market Share in Volume by Application in 2025 Figure 34. Europe Dry Powder Inhaler Device Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Dry Powder Inhaler Device Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Dry Powder Inhaler Device Sales Market Share in Value by Application in 2025 Figure 37. Latin America Dry Powder Inhaler Device Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Dry Powder Inhaler Device Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Dry Powder Inhaler Device Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Dry Powder Inhaler Device Sales Market Share in Value by Application in 2025 Figure 41. North America Dry Powder Inhaler Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Dry Powder Inhaler Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Dry Powder Inhaler Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Dry Powder Inhaler Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dry Powder Inhaler Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Dry Powder Inhaler Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dry Powder Inhaler Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dry Powder Inhaler Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dry Powder Inhaler Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Dry Powder Inhaler Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dry Powder Inhaler Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Dry Powder Inhaler Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dry Powder Inhaler Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Dry Powder Inhaler Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dry Powder Inhaler Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Dry Powder Inhaler Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dry Powder Inhaler Device Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Dry Powder Inhaler Device Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dry Powder Inhaler Device Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Dry Powder Inhaler Device Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Dry Powder Inhaler Device Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Dry Powder Inhaler Device Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose
  • Multi Dose
Applications
  • Asthma
  • COPD
  • Others
Companies covered
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Chiesi
  • Cipla
  • 3M
  • Hovione
  • Mannkind
  • Mylan
  • Novartis
  • Schering/Merck
  • Teva
  • Vectura

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dry Powder Inhaler Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dry Powder Inhaler Device Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dry Powder Inhaler Device Market by Type
  6. 1.3.1 Single Dose
  7. 1.3.2 Multi Dose
  8. 1.4 Global Dry Powder Inhaler Device Market Size by Type
  9. 1.4.1 Global Dry Powder Inhaler Device Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dry Powder Inhaler Device Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dry Powder Inhaler Device Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dry Powder Inhaler Device Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dry Powder Inhaler Device Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dry Powder Inhaler Device Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dry Powder Inhaler Device Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dry Powder Inhaler Device Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dry Powder Inhaler Device Industry Trends
  2. 2.2 Dry Powder Inhaler Device Industry Drivers
  3. 2.3 Dry Powder Inhaler Device Industry Opportunities and Challenges
  4. 2.4 Dry Powder Inhaler Device Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dry Powder Inhaler Device Revenue (2021-2026)
  2. 3.2 Global Top Players by Dry Powder Inhaler Device Sales (2021-2026)
  3. 3.3 Global Top Players by Dry Powder Inhaler Device Price (2021-2026)
  4. 3.4 Global Dry Powder Inhaler Device Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dry Powder Inhaler Device Major Company Production Sites & Headquarters
  6. 3.6 Global Dry Powder Inhaler Device Company, Product Type & Application
  7. 3.7 Global Dry Powder Inhaler Device Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dry Powder Inhaler Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dry Powder Inhaler Device Tier 1, Tier 2, and Tier 3
4 Dry Powder Inhaler Device Regional Status and Outlook
  1. 4.1 Global Dry Powder Inhaler Device Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dry Powder Inhaler Device Historic Market Size by Region
  3. 4.2.1 Global Dry Powder Inhaler Device Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dry Powder Inhaler Device Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dry Powder Inhaler Device Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dry Powder Inhaler Device Forecasted Market Size by Region
  7. 4.3.1 Global Dry Powder Inhaler Device Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dry Powder Inhaler Device Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dry Powder Inhaler Device Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dry Powder Inhaler Device by Application
  1. 5.1 Dry Powder Inhaler Device Market by Application
  2. 5.1.1 Asthma
  3. 5.1.2 COPD
  4. 5.1.3 Others
  5. 5.2 Global Dry Powder Inhaler Device Market Size by Application
  6. 5.2.1 Global Dry Powder Inhaler Device Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dry Powder Inhaler Device Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dry Powder Inhaler Device Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dry Powder Inhaler Device Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dry Powder Inhaler Device Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dry Powder Inhaler Device Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dry Powder Inhaler Device Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dry Powder Inhaler Device Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GlaxoSmithKline
  2. 6.1.1 GlaxoSmithKline Company Information
  3. 6.1.2 GlaxoSmithKline Business Overview
  4. 6.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
  6. 6.1.5 GlaxoSmithKline Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Chiesi
  20. 6.4.1 Chiesi Company Information
  21. 6.4.2 Chiesi Business Overview
  22. 6.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
  24. 6.4.5 Chiesi Recent Developments
  25. 6.5 Cipla
  26. 6.5.1 Cipla Company Information
  27. 6.5.2 Cipla Business Overview
  28. 6.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
  30. 6.5.5 Cipla Recent Developments
  31. 6.6 3M
  32. 6.6.1 3M Company Information
  33. 6.6.2 3M Business Overview
  34. 6.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 3M Dry Powder Inhaler Device Product Portfolio
  36. 6.6.5 3M Recent Developments
  37. 6.7 Hovione
  38. 6.7.1 Hovione Company Information
  39. 6.7.2 Hovione Business Overview
  40. 6.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
  42. 6.7.5 Hovione Recent Developments
  43. 6.8 Mannkind
  44. 6.8.1 Mannkind Company Information
  45. 6.8.2 Mannkind Business Overview
  46. 6.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
  48. 6.8.5 Mannkind Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
  60. 6.10.5 Novartis Recent Developments
  61. 6.11 Schering/Merck
  62. 6.11.1 Schering/Merck Company Information
  63. 6.11.2 Schering/Merck Business Overview
  64. 6.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
  66. 6.11.5 Schering/Merck Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Dry Powder Inhaler Device Product Portfolio
  72. 6.12.5 Teva Recent Developments
  73. 6.13 Vectura
  74. 6.13.1 Vectura Company Information
  75. 6.13.2 Vectura Business Overview
  76. 6.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
  78. 6.13.5 Vectura Recent Developments
7 North America by Country
  1. 7.1 North America Dry Powder Inhaler Device Sales by Country
  2. 7.1.1 North America Dry Powder Inhaler Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dry Powder Inhaler Device Sales by Country (2021-2026)
  4. 7.1.3 North America Dry Powder Inhaler Device Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dry Powder Inhaler Device Market Size by Country
  6. 7.2.1 North America Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dry Powder Inhaler Device Market Size by Country (2021-2026)
  8. 7.2.3 North America Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dry Powder Inhaler Device Sales by Country
  2. 8.1.1 Europe Dry Powder Inhaler Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dry Powder Inhaler Device Sales by Country (2021-2026)
  4. 8.1.3 Europe Dry Powder Inhaler Device Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dry Powder Inhaler Device Market Size by Country
  6. 8.2.1 Europe Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dry Powder Inhaler Device Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dry Powder Inhaler Device Sales by Country
  2. 9.1.1 Asia-Pacific Dry Powder Inhaler Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dry Powder Inhaler Device Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dry Powder Inhaler Device Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dry Powder Inhaler Device Market Size by Country
  6. 9.2.1 Asia-Pacific Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dry Powder Inhaler Device Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dry Powder Inhaler Device Sales by Country
  2. 10.1.1 South America Dry Powder Inhaler Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dry Powder Inhaler Device Sales by Country (2021-2026)
  4. 10.1.3 South America Dry Powder Inhaler Device Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dry Powder Inhaler Device Market Size by Country
  6. 10.2.1 South America Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dry Powder Inhaler Device Market Size by Country (2021-2026)
  8. 10.2.3 South America Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dry Powder Inhaler Device Sales by Country
  2. 11.1.1 Middle East and Africa Dry Powder Inhaler Device Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dry Powder Inhaler Device Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dry Powder Inhaler Device Market Size by Country
  6. 11.2.1 Middle East and Africa Dry Powder Inhaler Device Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dry Powder Inhaler Device Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dry Powder Inhaler Device Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dry Powder Inhaler Device Value Chain Analysis
  2. 12.1.1 Dry Powder Inhaler Device Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dry Powder Inhaler Device Production Mode & Process
  7. 12.2 Dry Powder Inhaler Device Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dry Powder Inhaler Device Distributors
  10. 12.2.3 Dry Powder Inhaler Device Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst